|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1501 M Street, NW |
Address2 | Suite 300 |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Park Ridge |
State | IL |
Zip Code | 60068-2573 |
Country | USA |
|
5. Senate ID# 3388-12
|
||||||||
|
6. House ID# 315460000
|
TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Manuel Bonilla, Chief Advocacy Officer |
Date | 01/16/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 574, Medicare Physician Payment Innovation Act
H.R. 1427, Truth in Healthcare Marketing Act of 2013
H.R. 1331, Electronic Health Records Improvement Act
H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013; Sustainable Growth Rate
S.1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013
S.1444, Medicare Access to Rural Anesthesiology Act of 2013
H.R. 351, Protecting Seniors' Access to Medicare Act; IPAB
S.351, Protecting Seniors' Access to Medicare Act; IPAB
Budget Control Act of 2011: P.L. 112-25
Anesthesia Rural Pass Through
Historical Medicare payment undervaluation for anesthesiology services (33% problem)
Anesthesia Conversion Factor
Perioperative Surgical Home Model
Medicare Reform, Payment Issues: Medicare Sustainable Growth Rate repeal
Bundled payments
CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services
2014 Medicare Physician Fee Schedule Rule
CMS decision to decrease values of interlaminar epidural injections
CMS Value-Based purchasing
CMS Medicare Data Final Rule
CMS Proposed Rule on Sunshine Act
Conditions of Participation - Anesthesia services, opt-outs, supervision
Physician Quality Reporting System, PPACA, Sec. 3007 Quality Modifier implementation
President Obama's deficit reduction plans, IPAB cuts
Accountable Care Organizations
Graduate Medical Education Cuts
Medicare Local Coverage Determinations
HHS Plan for Retrospective Review of Existing Rules 2011 - Conditions of Participation
Value-based modifier - PPACA
Debt ceiling- Medicare sequestration
E-Prescribing
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Manuel |
Bonilla |
|
|
|
Sharon |
Merrick |
|
|
|
Michelle |
Mathy |
|
|
|
Lisa |
Pearlstein |
|
|
|
Grant |
Couch |
|
|
|
Maureen |
Amos |
|
|
|
Nora |
Matus |
|
House Senior Advisor & House Chief of Staff |
|
Amanda |
Ledford |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1427, Truth in Healthcare Marketing Act of 2013
H.R. 1173, Palliative Care Bill
H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013
Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee
DEA Scheduling Propofol
Comparative Effectiveness Research
HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use
HHS/OIG Anesthesia Practice Arrangements, Company Model
FDA Risk Evaluation and Mitigation Strategies
FDA Safe Use Initiative
Pain Management
Proposed Federal CME requirements by ONDCP
FTC Letters to States regarding Interventional Pain Medicine and Advanced Practice Nurses
Propofol Shortage - European Union Export Restrictions
Scope of Practice
FDA Operating Room Fires
State Exchanges pursuant to PPACA
FDA SEDASYS
FDA Patient Prescriber working group
FDA Sedation Initiative
Naloxone
ICD-10-CM/PCS and proposed delay of implementation date
HHS AIDE Action Plan
FDA Opioids
Prescription Drug Abuse
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Justice - Dept of (DOJ), Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Office of Management & Budget (OMB), Executive Office of the President (EOP), Defense - Dept of (DOD), Occupational Safety & Health Administration (OSHA), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Manuel |
Bonilla |
|
|
|
Sharon |
Merrick |
|
|
|
Michelle |
Mathy |
|
|
|
Lisa |
Pearlstein |
|
|
|
Grant |
Couch |
|
|
|
Maureen |
Amos |
|
|
|
Nora |
Matus |
|
House Senior Advisor & House Chief of Staff |
|
Amanda |
Ledford |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Veterans Affairs Advance Practice Registered Nurses - "VHA Nursing Handbook"
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Manuel |
Bonilla |
|
|
|
Sharon |
Merrick |
|
|
|
Michelle |
Mathy |
|
|
|
Lisa |
Pearlstein |
|
|
|
Grant |
Couch |
|
|
|
Maureen |
Amos |
|
|
|
Nora |
Matus |
|
House Senior Advisor & House Chief of Staff |
|
Amanda |
Ledford |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |